The New Nicotine Alliance’s latest international selection reports on research concerning e-cigarettes, regulatory risks in the EU, and US regulatory decisions.
The New Nicotine Alliance’s current digest reviews the latest international research findings and policy issues concerning vaping and harm reduction. The selection highlights a study conducted by CoEHAR across 29 countries involving 1,519 adults, which found that in individuals with no history of smoking who use e-cigarettes exclusively, respiratory symptoms are minimal and remain below the threshold of clinical significance.
On the regulatory front, Michael Ellis, former Assistant Director of INTERPOL, warns that the European Union’s planned nicotine tightening could boost the black market and organized crime. Concurrently, the US Food and Drug Administration (FDA) has clarified that mandatory digital age-verification technology on devices is not necessarily required for the authorization of flavored e-cigarettes.
In Brief
- According to CoEHAR’s survey of 1,519 people, respiratory symptoms in vapers who have never smoked remain below the threshold of clinical significance.
- The former Assistant Director of INTERPOL warned of a strengthening black market in relation to the planned EU nicotine restrictions.
- The US FDA has clarified that a built-in digital age lock is not a condition for the marketing of flavored e-cigarettes.
- The newsletter also covers, among other topics, the stalling of European tax negotiations and the impact of local flavor bans.
Source: NNA (vapers.org.uk)
This summary was prepared by artificial intelligence based on the original article.